PURPOSE: For individuals who have experienced debilitating upper extremity injury or amputation, hand transplantation holds the potential for drastic quality of life improvement. This potential depends on adequate nerve regeneration into the transplant and reanimation of graft musculature. In this study, we demonstrate the use of a murine heterotopic limb transplant model for evaluation of nerve regeneration in a composite tissue allograft (CTA). We also compare the effects of various immunosuppressive regimens on nerve regeneration in this model. METHODS: The study consisted of five groups of mice, all of which underwent heterotopic limb transplant with coaptation of the recipient and donor sciatic nerves. The groups received the following immunosuppressive regimens: group A (positive control)-syngeneic transplant, no immunosuppression; group B (negative control)-allogeneic transplant, no immunosuppression; group C-allogeneic transplant, FK-506 + MR1; group D-allogeneic transplant, MR1 + CTLA4-Ig; group E-syngeneic transplant, FK-506 treatment with preloading. RESULTS: Group B animals showed signs of transplant rejection as early as 5 days postoperatively. Except for one mouse from group C and one mouse from group D, all other animals had viable transplants and nerve regeneration present in the donor sciatic nerve at the 3-week endpoint of the study. CONCLUSIONS: To our knowledge, this represents the first report of the use of a mouse CTA model for evaluation of nerve regeneration. The mouse heterotopic limb transplant model will be a valuable tool for CTA research since it can be performed with more ease, and with less host morbidity and mortality than the mouse orthotopic model.
PURPOSE: For individuals who have experienced debilitating upper extremity injury or amputation, hand transplantation holds the potential for drastic quality of life improvement. This potential depends on adequate nerve regeneration into the transplant and reanimation of graft musculature. In this study, we demonstrate the use of a murine heterotopic limb transplant model for evaluation of nerve regeneration in a composite tissue allograft (CTA). We also compare the effects of various immunosuppressive regimens on nerve regeneration in this model. METHODS: The study consisted of five groups of mice, all of which underwent heterotopic limb transplant with coaptation of the recipient and donor sciatic nerves. The groups received the following immunosuppressive regimens: group A (positive control)-syngeneic transplant, no immunosuppression; group B (negative control)-allogeneic transplant, no immunosuppression; group C-allogeneic transplant, FK-506 + MR1; group D-allogeneic transplant, MR1 + CTLA4-Ig; group E-syngeneic transplant, FK-506 treatment with preloading. RESULTS: Group B animals showed signs of transplant rejection as early as 5 days postoperatively. Except for one mouse from group C and one mouse from group D, all other animals had viable transplants and nerve regeneration present in the donor sciatic nerve at the 3-week endpoint of the study. CONCLUSIONS: To our knowledge, this represents the first report of the use of a mouse CTA model for evaluation of nerve regeneration. The mouse heterotopic limb transplant model will be a valuable tool for CTA research since it can be performed with more ease, and with less host morbidity and mortality than the mouse orthotopic model.
Authors: Michael J Brenner; Susan E Mackinnon; Susan R Rickman; Andrés Jaramillo; Thomas H H Tung; Daniel A Hunter; T Mohanakumar Journal: Restor Neurol Neurosci Date: 2005 Impact factor: 2.406
Authors: Michael J Brenner; Ida K Fox; David H Kawamura; Vivian M Yu; James B Lowe; Daniel A Hunter; Susan E Mackinnon Journal: Laryngoscope Date: 2004-03 Impact factor: 3.325
Authors: Marco Lanzetta; Palmina Petruzzo; Jean Michel Dubernard; Raimund Margreiter; Frederic Schuind; Warren Breidenbach; Roberta Nolli; Stephan Schneeberger; Carlo van Holder; Vijay S Gorantla; Guoxian Pei; Jinmin Zhao; Xinying Zhang Journal: Transpl Immunol Date: 2007-04-09 Impact factor: 1.708
Authors: Palmina Petruzzo; Marco Lanzetta; Jean Michel Dubernard; Raimund Margreiter; Frédéric Schuind; Warren Breidenbach; Roberta Nolli; Stephan Schneeberger; Carlo van Holder; Christina Kaufman; Jerzy Jablecki; Luis Landin; Pedro Cavadas Journal: Transplantation Date: 2008-08-27 Impact factor: 4.939
Authors: Rahul Kasukurthi; Michael J Brenner; Amy M Moore; Arash Moradzadeh; Wilson Z Ray; Katherine B Santosa; Susan E Mackinnon; Daniel A Hunter Journal: J Neurosci Methods Date: 2009-08-31 Impact factor: 2.390
Authors: Ying Yan; Matthew D Wood; Amy M Moore; Alison K Snyder-Warwick; Daniel A Hunter; Piyaraj Newton; Louis Poppler; Thomas H Tung; Philip J Johnson; Susan E Mackinnon Journal: Hand (N Y) Date: 2016-01-14